Literature DB >> 22733156

The early cellular signatures of protective immunity induced by live viral vaccination.

Siegfried Kohler1, Nicole Bethke, Matthias Böthe, Sophie Sommerick, Marco Frentsch, Chiara Romagnani, Matthias Niedrig, Andreas Thiel.   

Abstract

Here, we have used primary vaccination of healthy donors with attenuated live yellow fever virus 17D (YFV-17D) as a model to study the generation of protective immunity. In short intervals after vaccination, we analyzed the induction of YFV-17D specific T- and B-cell immunity, bystander activation, dendritic cell subsets, changes in serum cytokine levels, and YFV-17D-specific antibodies. We show activation of innate immunity and a concomitant decline of numbers of peripheral blood T and B cells. An early peak of antigen-specific T cells at day 2, followed by mobilization of innate immune cells, preceded the development of maximal adaptive immunity against YFV-17D at day 14 after vaccination. Interestingly, potent adaptive immunity as measured by high titers of neutralizing YFV-17D-specific antibodies, correlated with early activation and recruitment of YFV-17D-specific CD4(+) T cells and higher levels of sIL-6R. Thus our data might provide new insights into the interplay of innate and adaptive immunity for the induction of protective immunity.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733156     DOI: 10.1002/eji.201142306

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  The yellow fever 17D virus as a platform for new live attenuated vaccines.

Authors:  Myrna C Bonaldo; Patrícia C Sequeira; Ricardo Galler
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

Review 2.  Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Authors:  Huabin Liang; Min Lee; Xia Jin
Journal:  Cell Mol Immunol       Date:  2015-10-05       Impact factor: 11.530

3.  Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.

Authors:  Stephen Tottey; Yoko Shoji; R Mark Jones; Jessica A Chichester; Brian J Green; Konstantin Musiychuk; Huaxin Si; Slobodanka D Manceva; Amy Rhee; Moneim Shamloul; Joey Norikane; Rosane C Guimarães; Elena Caride; Andrea N M R Silva; Marisol Simões; Patricia C C Neves; Renato Marchevsky; Marcos S Freire; Stephen J Streatfield; Vidadi Yusibov
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

Review 4.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

5.  Dynamics of the cytotoxic T cell response to a model of acute viral infection.

Authors:  William S DeWitt; Ryan O Emerson; Paul Lindau; Marissa Vignali; Thomas M Snyder; Cindy Desmarais; Catherine Sanders; Heidi Utsugi; Edus H Warren; Juliana McElrath; Karen W Makar; Anna Wald; Harlan S Robins
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

6.  Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

Authors:  Eddie A James; Rebecca E LaFond; Theresa J Gates; Duy T Mai; Uma Malhotra; William W Kwok
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

7.  B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.

Authors:  Samantha M Townsley; Gina C Donofrio; Ningbo Jian; David J Leggat; Vincent Dussupt; Letzibeth Mendez-Rivera; Leigh Anne Eller; Lauryn Cofer; Misook Choe; Philip K Ehrenberg; Aviva Geretz; Syna Gift; Rebecca Grande; Anna Lee; Caroline Peterson; Mary Bryson Piechowiak; Bonnie M Slike; Ursula Tran; M Gordon Joyce; Ivelin S Georgiev; Morgane Rolland; Rasmi Thomas; Sodsai Tovanabutra; Nicole A Doria-Rose; Victoria R Polonis; John R Mascola; Adrian B McDermott; Nelson L Michael; Merlin L Robb; Shelly J Krebs
Journal:  Cell Host Microbe       Date:  2021-03-03       Impact factor: 21.023

Review 8.  Questions regarding the safety and duration of immunity following live yellow fever vaccination.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2016-06-20       Impact factor: 5.683

9.  Vaccination Expands Antigen-Specific CD4+ Memory T Cells and Mobilizes Bystander Central Memory T Cells.

Authors:  Eleonora Li Causi; Suraj C Parikh; Lindsey Chudley; David M Layfield; Christian H Ottensmeier; Freda K Stevenson; Gianfranco Di Genova
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

10.  Early IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responses.

Authors:  Patrícia C C Neves; Juliana R Santos; Luciana N Tubarão; Myrna C Bonaldo; Ricardo Galler
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.